| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $337.7M | -28.8% |
| Cost of Revenue | $236.4M | -26.3% |
| Gross Profit | $101.3M | -34.0% |
| R&D Expense | $52.3M | +2.2% |
| SG&A Expense | $50.9M | -3.0% |
| Operating Income | -$5.2M | -106.3% |
| Pre-tax Income | -$2.9M | -103.9% |
| Income Tax | $5.2M | -70.1% |
| Net Income | -$8.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225.5M | -19.3% |
| Accounts Receivable | $35.4M | -30.6% |
| Inventory | $39.9M | +1.3% |
| Current Assets | $337.9M | -17.4% |
| Total Assets | $516.6M | -11.5% |
| Current Liabilities | $47.2M | -44.7% |
| Total Liabilities | $88.5M | -32.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.2M | -94.1% |
| Capital Expenditures | $23.4M | -27.4% |
| Investing Cash Flow | -$24.9M | +20.7% |
| Financing Cash Flow | -$12.7M | +64.1% |
| Free Cash Flow | -$18.2M | -132.8% |
| -114.2% |
| EPS (Basic) | -$0.18 | -114.3% |
| EPS (Diluted) | -$0.18 | -114.9% |
| Stockholders' Equity |
| $428.2M |
| -5.4% |